Showing 1 - 7 results of 7 for search 'Maurizio Civelli', query time: 0.05s Refine Results
  1. 1
    Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease

    Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease by Fabrizio Facchinetti, Maurizio Civelli, Dave Singh, Alberto Papi, Aida Emirova, Mirco Govoni

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Harnessing the translational power of bleomycin model: new insights to guide drug discovery for idiopathic pulmonary fibrosis

    Harnessing the translational power of bleomycin model: new insights to guide drug discovery for idiopathic pulmonary fibrosis by Annalisa Murgo, Fabio Bignami, Giuseppina Federico, Gino Villetti, Maurizio Civelli, Angelo Sala, Daniela Miglietta

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Corrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder

    Corrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder by Cataldo Martucci, Andrew Dennis Allen, Nadia Moretto, Valentina Bagnacani, Alessandro Fioni, Riccardo Patacchini, Maurizio Civelli, Gino Villetti, Fabrizio Facchinetti

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    CHF6001 Inhibits NF-κB Activation and Neutrophilic Recruitment in LPS-Induced Lung Inflammation in Mice

    CHF6001 Inhibits NF-κB Activation and Neutrophilic Recruitment in LPS-Induced Lung Inflammation in Mice by Fabio F. Stellari, Angelo Sala, Angelo Sala, Francesca Ruscitti, Carola Buccellati, Andrew Allen, Patrizia Risé, Maurizio Civelli, Gino Villetti

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder

    CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder by Cataldo Martucci, Andrew Dennis Allen, Nadia Moretto, Valentina Bagnacani, Alessandro Fioni, Riccardo Patacchini, Maurizio Civelli, Gino Villetti, Fabrizio Facchinetti

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Phosphodiesterase 4 inhibitors attenuate virus‐induced activation of eosinophils from asthmatics without affecting virus binding

    Phosphodiesterase 4 inhibitors attenuate virus‐induced activation of eosinophils from asthmatics without affecting virus binding by Yanaika Shari Sabogal Piñeros, Tamara Dekker, Barbara Smids, Christof J. Majoor, Lara Ravanetti, Gino Villetti, Maurizio Civelli, Fabrizio Facchinetti, René Lutter

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Quantification of Lung Fibrosis in IPF-Like Mouse Model and Pharmacological Response to Treatment by Micro-Computed Tomography

    Quantification of Lung Fibrosis in IPF-Like Mouse Model and Pharmacological Response to Treatment by Micro-Computed Tomography by Francesca Ruscitti, Francesca Ravanetti, Valeria Bertani, Luisa Ragionieri, Laura Mecozzi, Nicola Sverzellati, Mario Silva, Livia Ruffini, Valentina Menozzi, Maurizio Civelli, Gino Villetti, Franco Fabio Stellari

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: